ǰÑÔ
Ѱ³£×ù´¯ÊÇȬ´¯(acne)µä·¶ÌåÏÖ£¬ÓÉ4¸ö»ù±¾·¢²¡»·½Ú×é³É£¬¼´ðî´¯±ûËá¸Ë¾úºÍÓÅÊÆ»¯Å§¾úѬȾ¡¢Ã«ÄÒÆ¤Ö¬ÏÙµ¼¹Ü½Ç»¯Òì³£ºÍ·Û´ÌÌìÉú¡¢ÐÛ¼¤ËØºÍÆ¤Ö¬ÏÙÉøÍ¸Òì³£ºÍ¾Ö²¿Ñ×Ö¢·´Ó¦¡£ÏÖÔÚ£¬»¹²»¿É½¨Éè°üÀ¨ÉÏÊö4¸ö²¡Àí»·½ÚµÄ¶¯Îï¼²²¡Ä£×Ó£¬µ«¿É»®·ÖÓÕµ¼¼²²¡»ù±¾²¡Àí»·½ÚÖ®Ò»µÄ·Û´ÌÌìÉú¼°Ê¹ÓÃÕý³£¶¯ÎïÉúÎïÑ§ÌØÕ÷µÄ½ð»ÆµØÊóв²¿Æ¤Ö¬ÏÙÉ«ËØ°ß½¨ÉèÕûÌåÄ£×Ó¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Î½ð»ÆµØÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
Ƥ֬ÏÙ¹¦Ð§¿º½øÊÇѰ³£ðî´¯·¢²¡»·½ÚÖ®Ò»£¬½ð»ÆµØÊó±³²¿Æ¤Ö¬ÏÙÉ«ËØ°ß£¨Òà³ÆÐ²²¿Æ÷¹Ù£©ÊÇÐÛ¼¤ËØÒÀÀµÆ÷¹Ù£¬¿ÉÓÃÓÚÑо¿Ò©ÎÐÛ¼¤Ëؼ°¿¹Æ¤Ö¬ÏÙÔöÉúÑÄÐÔ¡£
¡¾Ä£×ÓÌØµã¡¿£º
ʵÑ鶯ÎïΪÐÛÐÔ½ð»ÆµØÊ󣬵¥ÁýËÇÑø£¬ÊµÑéÇéÐμ°ËÇÑøÌõ¼þÒªºã¶¨¡£ÈçÑо¿ÍâÓÃÒ©£¬ÊµÑéǰÓõçÌêµ¶Ìê롣ΪÁ˱ÜÃ⶯Îï×ÔÌò£¬ÔÚÿ´ÎͿҩºó±ØÐèÓÐÓÃÀο¿¶¯Îï¾±²¿»òÈ«ÉíÖÁÉÙ3Сʱ¡£ ¶¯ÎïÓÒ²àÆ¤Ö¬ÏÙ°ßÖðÈÕͿҩ2´Î£¬×ó²à²»´¦Öóͷ££¬×÷Êý¾ÝУÕýÓã¬ÁíÉè±ÈÕÕ×é¡£²â¶¨Æ¤Ö¬ÏÙ°ßµÄ×î´óÖ±¾¶DÖµ¼°×î´óºá¾¶HÖµ£¬ÆäÊýֵת±äÓëÆ¤Ö¬ÏÙ°ßÌå»ý³Ê½ÏºÃµÄÕýÏà¹Ø¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
±¾Ä£×ÓʹÓö¯ÎïÉúÎïÑ§ÌØÕ÷ÓëÈËÀ༲²¡ÏàËÆÐÔ×÷¼²²¡Ä£×Ó£¬³ÆÉúÎïҽѧ¶¯ÎïÄ£×Ó¡£ÒÔÐÎ̬ѧҪÁì×÷ҩЧ¶¨Á¿ÆÀ¼Û£¬ÓÐÒ»¶¨µÄ¼ÛÖµ¡£
²Î¿¼ÎÄÏ×£º
1.Pewig G. Skin Models: Models Lo study follicular diseases. Heidelberg:Springer Verlag, 1986
2.Weissmann A, Bowden J,Frank 8. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ. Arch Dermatol, 1985, 121 (1):57-62
3.Gomez EC. Models in Dermatology. Basel: Karger, 1985